Company news in brief
Novo Nordisk offers billions for AblynxDanish drugmaker Novo Nordisk has made a 2.6 billion euros (US$3.12 billion) bid for Belgian biotech group Ablynx, the latest offer by a big ...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 10:00.
Comments
Namibian Sun
No comments have been left on this article